Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1919 RabdosiinSummary: Rabdosiin is a caffeic acid tetramer. -
BA1920 Apelin-12Summary: Apelin-12 is one of the most potent C-terminal fragments of the peptide with high affinity for the orphan receptor receptor. -
BA1921 TAK-220Summary: TAK-220 is a selective, orally available antagonist. -
BA1923 StampidineSummary: Stampidine is a nucleoside reverse transcriptase inhibitor with potent, broad-spectrum anti activity. -
BA1924 GSK3532795Summary: GSK3532795 is a potent, orally available, second generation maturation inhibitor. -
BA1925 ElsulfavirineSummary: Reverse transcriptase inhibitors of infection. -
BA1926 LetrazurilSummary: A compound. -
BA1927 CensavudineSummary: Censavudine (OBP-601; BMS-986001), a nucleoside analog, is a nucleoside reverse transcriptase inhibitor. -
BA1928 LovirideSummary: Loviride (R89439) is a non-nucleoside reverse transcriptase inhibitor. -
BA1929 TrovirdineSummary: Trovirdine inhibits HIV-1 reverse transcription.

